Cargando…

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection

Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell malignancies. However, whether lytic EBV infection also contributes to tumors is unclear, although the association between malaria infection and Burkitt lymphomas (BLs) may involve excessive lytic EBV replicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bristol, Jillian A., Djavadian, Reza, Albright, Emily R., Coleman, Carrie B., Ohashi, Makoto, Hayes, Mitchell, Romero-Masters, James C., Barlow, Elizabeth A., Farrell, Paul J., Rochford, Rosemary, Kalejta, Robert F., Johannsen, Eric C., Kenney, Shannon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082571/ https://www.ncbi.nlm.nih.gov/pubmed/30052684 http://dx.doi.org/10.1371/journal.ppat.1007179

Ejemplares similares

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms
por: Djavadian, Reza, et al.
Publicado: (2018)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
por: Romero-Masters, James C., et al.
Publicado: (2018)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters
por: Dickerson, Sarah J., et al.
Publicado: (2009)

An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription
por: Djavadian, Reza, et al.
Publicado: (2016)

Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species
por: Zhao, Ling, et al.
Publicado: (2015)

Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
por: Kraus, Richard J., et al.
Publicado: (2017)

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection
por: Romero-Masters, James C., et al.
Publicado: (2020)

Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1
por: Bernaudat, Florent, et al.
Publicado: (2021)

MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus
por: Lin, Ting-Yu, et al.
Publicado: (2014)

Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein
por: Barabas, Sascha, et al.
Publicado: (2008)

Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ
por: Singh, Deo R., et al.
Publicado: (2023)

The B-Cell Specific Transcription Factor, Oct-2, Promotes Epstein-Barr Virus Latency by Inhibiting the Viral Immediate-Early Protein, BZLF1
por: Robinson, Amanda R., et al.
Publicado: (2012)

Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1
por: De La Cruz-Herrera, Carlos F., et al.
Publicado: (2023)

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells
por: Nawandar, Dhananjay M., et al.
Publicado: (2015)

Epstein-Barr Virus Evades CD4(+) T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2
por: Zuo, Jianmin, et al.
Publicado: (2011)

BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
por: Woellmer, Anne, et al.
Publicado: (2012)

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency
por: Murata, Takayuki, et al.
Publicado: (2013)

Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
por: MacNeil, A, et al.
Publicado: (2003)

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice
por: Li, Chunrong, et al.
Publicado: (2020)

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells
por: Bristol, Jillian A., et al.
Publicado: (2022)

Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes
por: Singh, Deo R., et al.
Publicado: (2022)

Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
por: Yap, Lee Fah, et al.
Publicado: (2022)

IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt’s lymphoma cells
por: Jordi, Marc, et al.
Publicado: (2017)

A Role for the Nucleosome Assembly Proteins TAF-Iβ and NAP1 in the Activation of BZLF1 Expression and Epstein-Barr Virus Reactivation
por: Mansouri, Sheila, et al.
Publicado: (2013)

1778. Epstein–Barr Virus Genetic Diversity: Evaluation of BZLF1 Variants among Bone Marrow Transplant Patients and Individuals with Infectious Mononucleosis
por: Abdulnoor, Mariana, et al.
Publicado: (2019)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
por: Yiu, Ching-Yi, et al.
Publicado: (2010)

Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins
por: Li, Lili, et al.
Publicado: (2012)

Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
por: Rosemarie, Quincy, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53
por: Dreyfus, David H, et al.
Publicado: (2011)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
por: Lee, Jaeyeun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e6jqde3vq3i92lum8jsien1lgh